Literature DB >> 3697085

Selective inhibition of the cytopathic effect of type A influenza viruses by oligodeoxynucleotides covalently linked to an intercalating agent.

A Zerial1, N T Thuong, C Hélène.   

Abstract

Oligodeoxynucleotides covalently linked to an acridine derivative were targeted to part of the 3'-terminal sequence which is common to the eight RNAs of type A influenza viruses. The cytopathic effect of the virus on MDCK cells in culture was strongly decreased by a heptanucleotide covalently attached to the acridine ring. Control experiments using other oligonucleotide sequences showed that the effect was specific for the complementary sequence of the 3'-terminal region of the viral RNAs. The RNA transcriptase reaction of a type A virus was also selectively inhibited in vitro by the heptanucleotide-acridine conjugate. A type B influenza virus was used as a control. The common sequence at the 3' end of its eight viral RNAs is different from that of type A viruses. Three mismatches were expected with the heptanucleotide which was fully complementary to type A viral RNAs. This heptanucleotide had no effect on the cytopathic effect of a type B influenza virus. These results demonstrate that viral RNAs are specific targets for the oligonucleotide-acridine conjugate that inhibits the cytopathic effect of type A influenza viruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3697085      PMCID: PMC306539          DOI: 10.1093/nar/15.23.9909

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  Polyacrylamide gel electrophoresis of influenza virus RNA.

Authors:  M W Pons; G K Hirst
Journal:  Virology       Date:  1968-02       Impact factor: 3.616

2.  Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription.

Authors:  J Braam; I Ulmanen; R M Krug
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

Review 3.  Structure and function of the influenza virus genome.

Authors:  J W McCauley; B W Mahy
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

Review 4.  The gene structure and replication of influenza virus.

Authors:  R A Lamb; P W Choppin
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

Review 5.  Antiviral agents as adjuncts in cancer chemotherapy.

Authors:  W M Shannon; F M Schabel
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

6.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

7.  Oligo(alpha-deoxynucleotide)s covalently linked to intercalating agents: differential binding to ribo- and deoxyribopolynucleotides and stability towards nuclease digestion.

Authors:  N T Thuong; U Asseline; V Roig; M Takasugi; C Hélène
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Functional analysis of influenza RNA polymerase activity by the use of caps, oligonucleotides and polynucleotides.

Authors:  S Stridh; B Oberg; J Chattopadhyaya; S Josephson
Journal:  Antiviral Res       Date:  1981-06       Impact factor: 5.970

9.  The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity.

Authors:  U Desselberger; V R Racaniello; J J Zazra; P Palese
Journal:  Gene       Date:  1980-02       Impact factor: 3.688

10.  Oligodeoxynucleotides covalently linked to intercalating dyes as base sequence-specific ligands. Influence of dye attachment site.

Authors:  U Asseline; F Toulme; N T Thuong; M Delarue; T Montenay-Garestier; C Hélène
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598

View more
  27 in total

1.  Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4.

Authors:  M Kulka; C C Smith; L Aurelian; R Fishelevich; K Meade; P Miller; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 2.  Genetic engineering of plants for virus resistance.

Authors:  F Gadani; L M Mansky; R Medici; W A Miller; J H Hill
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds.

Authors:  P J Furdon; Z Dominski; R Kole
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

4.  Alpha-DNA VIII: thermodynamic parameters of complexes formed between the oligo-alpha-deoxynucleotides: alpha-d(GGAAGG) and alpha-d(CCTTCC) and their complementary oligo-beta-deoxynucleotides: beta-d(CCTTCC) and beta-d(GGAAGG) are different.

Authors:  J Paoletti; D Bazile; F Morvan; J L Imbach; C Paoletti
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

5.  Inhibition of human immunodeficiency virus (HIV-1) replication by synthetic oligo-RNA derivatives.

Authors:  S Shibahara; S Mukai; H Morisawa; H Nakashima; S Kobayashi; N Yamamoto
Journal:  Nucleic Acids Res       Date:  1989-01-11       Impact factor: 16.971

6.  Sequence dependent effects in methylphosphonate deoxyribonucleotide double and triple helical complexes.

Authors:  L Kibler-Herzog; B Kell; G Zon; K Shinozuka; S Mizan; W D Wilson
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

7.  Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.

Authors:  J M Leiter; S Agrawal; P Palese; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16.

Authors:  A Storey; D Oates; L Banks; L Crawford; T Crook
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

9.  Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates.

Authors:  P S Sarin; S Agrawal; M P Civeira; J Goodchild; T Ikeuchi; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

Authors:  S Agrawal; J Goodchild; M P Civeira; A H Thornton; P S Sarin; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.